Shuwen Biotech Announces South African Clinical Study of CercaTest REDTM for Short-Term Prediction of Preeclampsia

Source Summary

Shuwen Biotech today announced the initiation of a prospective clinical study by leading experts in South Africa evaluating CercaTest REDTM, its novel